{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-016507","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2024-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.377702+00:00","generated_at":"2026-06-05T16:41:22.965862+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"China Pharma announces 1-for-5 reverse stock split effective March 6, 2024","bullets":["Reverse split at 1-for-5 ratio, effective March 6, 2024; every 5 pre-split shares convert to 1 post-split share.","No fractional shares issued; any fractional shares will be rounded up to the next whole number.","Trading continues on NYSE American under symbol CPHI; new CUSIP is 16941T 302.","Split approved by Board on Oct 16, 2023 and by stockholders on Dec 17, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-016507","json":"https://secwatch.observer/filing/0001213900-24-016507.json","markdown":"https://secwatch.observer/filing/0001213900-24-016507.md","text":"https://secwatch.observer/filing/0001213900-24-016507.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024016507/0001213900-24-016507-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024016507/ea0200603-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T16:41:22.965862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}